Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 μg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling

被引：23
作者：
Ali, Moazzam [1 ]
Bahamondes, Luis [2 ]
Landoulsi, Sihem Bent [1 ]
机构：
[1] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland
[2] Univ Estadual Campinas, Dept Obstet & Gynaecol, Fac Med Sci, Family Planning Clin, Sao Paulo, Brazil
来源：
GLOBAL HEALTH-SCIENCE AND PRACTICE | 2017年 / 5卷 / 04期
关键词：
WOMEN; DEVICES;
D O I：
10.9745/GHSP-D-17-00296
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：534 / 539
页数：6
相关论文
共 27 条
[1]   Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant [J].
Ali, Moazzam ;
Akin, Ayse ;
Bahamondes, Luis ;
Brache, Vivian ;
Habib, Ndema ;
Landoulsi, Sihem ;
Hubacher, David .
HUMAN REPRODUCTION, 2016, 31 (11) :2491-2498
[2]   A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls [J].
Bahamondes, Luis ;
Brache, Vivian ;
Meirik, Olav ;
Ali, Moazzam ;
Habib, Ndema ;
Landoulsi, Sihem .
HUMAN REPRODUCTION, 2015, 30 (11) :2527-2538
[3]   Long-acting Reversible Contraceptive Methods for Adolescents with Chronic Medical Problems [J].
Bryant, Amy G. ;
Stuart, Gretchen S. ;
Narasimhan, Subasri .
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2012, 25 (06) :347-351
[4]   Family Planning as a Cost-Saving Preventive Health Service [J].
Cleland, Kelly ;
Peipert, Jeffrey F. ;
Westhoff, Carolyn ;
Spear, Scott ;
Trussell, James .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18) :e37(1)
[5]   Side effects unrelated to disease activity and acceptability of highly effective contraceptive methods in women with systemic lupus erythematosus: a randomized, clinical trial [J].
Cravioto, Maria-del-Carmen ;
Jimenez-Santana, Luisa ;
Mayorga, Julio ;
Seuc, Armando H. .
CONTRACEPTION, 2014, 90 (02) :147-153
[6]   Intrauterine devices and intrauterine systems [J].
Crosignani, P. G. .
HUMAN REPRODUCTION UPDATE, 2008, 14 (03) :197-208
[7]   Mechanisms that explain the contraceptive action of progestin implants for women [J].
Croxatto, HB .
CONTRACEPTION, 2002, 65 (01) :21-27
[8]   EVALUATION OF THE CLINICAL-PERFORMANCE OF A LEVONORGESTREL-RELEASING IUD, UP TO 7 YEARS OF USE, IN CAMPINAS, BRAZIL [J].
DIAZ, J ;
FAUNDES, A ;
DIAZ, M ;
MARCHI, N .
CONTRACEPTION, 1993, 47 (02) :169-175
[9]   CLINICAL-TRIAL WITH 3-KETO-DESOGESTREL SUBDERMAL IMPLANTS [J].
DIAZ, S ;
PAVEZ, M ;
MOOYOUNG, AJ ;
BARDIN, CW ;
CROXATTO, HB .
CONTRACEPTION, 1991, 44 (04) :393-408
[10]   Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system [J].
Hidalgo, Maria M. ;
Hidalgo-Regina, Creusa ;
Bahamondes, M. Valeria ;
Monteiro, Ilza ;
Petta, Carlos A. ;
Bahamondes, Luis .
CONTRACEPTION, 2009, 80 (01) :84-89
123